16.11.2015 Views

December 2015 Science Journal

The December 2015 issue of the Science Journal from the Eberly College of Science at Penn State University

The December 2015 issue of the Science Journal from the Eberly College of Science at Penn State University

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Alumni News<br />

Five Honored with Penn State’s<br />

Outstanding <strong>Science</strong> Alumni Award<br />

The Penn State University Eberly College of<br />

<strong>Science</strong> has selected five alumni to be honored<br />

with the Outstanding <strong>Science</strong> Alumni Award<br />

for <strong>2015</strong>. The Board of Directors of the Eberly<br />

College of <strong>Science</strong> Alumni Society established<br />

this award to recognize alumni who have a record<br />

of significant professional achievements in<br />

their field and who are outstanding role models<br />

for students in the college. Receiving this award<br />

are:<br />

Donna Bortner, ’84 B.S. Microbiology<br />

Alexa Dembek, ’91 Ph.D. Chemistry<br />

Sudhir Kumar, ’96, Ph.D. Genetics<br />

Caryl Russo Singer, ’82 B.S. Biology<br />

Larry Travis, ’71 Ph.D. Astronomy<br />

Donna Bortner is the chief executive officer<br />

at TransViragen, Inc, a company she cofounded<br />

in 2009. TransViragen focuses on the<br />

generation and analysis of genetically modified<br />

cell lines and animal models for scientific research.<br />

The company provides a variety of custom<br />

services to a growing list of clients in the<br />

government, pharmaceutical, biotechnology and<br />

academic sectors.<br />

Prior to establishing TransViragen, Bortner<br />

worked for nearly twenty years in the pharmaceutical<br />

industry at GlaxoSmithKline. She<br />

joined GlaxoSmithKline as a postdoctoral fellow<br />

in the pharmacology department, where her<br />

research entailed the development of animal<br />

models to study mechanisms of cancer relevant<br />

to human disease. She went on to hold positions<br />

of increasing responsibility in the research division,<br />

most recently as the head of the company’s<br />

transgenics, viral-vectors, and sequencing operations<br />

in the United States. In this position,<br />

she led a team of scientists in research efforts<br />

focused on the development and application of<br />

genomic technologies to drug discovery and development,<br />

with particular emphasis on genetically<br />

modified rodent models. She also served<br />

as the chair of the institutional-biosafety and<br />

animal-welfare committees.<br />

After graduating with a bachelor’s degree in<br />

microbiology with honors and high distinction<br />

from Penn State in 1984, she worked at the National<br />

Animal Disease Center until 1987. She<br />

went on to earn a doctoral degree in 1992 in Microbiology<br />

and Immunology at Duke University,<br />

where she was a National <strong>Science</strong> Foundation<br />

graduate fellow.<br />

Alexa Dembek is the director of Central<br />

Research and Development at DuPont. She is<br />

responsible for the development of opportunities<br />

involving transformational emerging science.<br />

Dembek joined DuPont in 1991 as a research<br />

chemist. In 1995, she took the position of tech-<br />

nical manager at DuPont Protection Technologies.<br />

As her career progressed, she assumed<br />

roles that spanned a range of areas, including<br />

supply chain, operations, sales, marketing, and<br />

business leadership.<br />

In 2005, Dembek was assigned leadership<br />

roles in DuPont Building Innovations, first as<br />

a commercial business segment manager and<br />

later as the North American marketing manager.<br />

In 2006, she transferred to DuPont Performance<br />

Polymers. In 2011, she was appointed<br />

the regional director of the Americas region.<br />

Most recently, Dembek was named the global<br />

business director for Dupont’s cross-business<br />

Energy Storage venture.<br />

Dembek holds a bachelor’s degree in chemistry<br />

from Northern Illinois University. She completed<br />

her Ph.D. degree in chemistry in 1991 at<br />

Penn State.<br />

Sudhir Kumar is the Laura H. Carnell Professor<br />

and the director of the Institute for Genomics<br />

and Evolutionary Medicine at Temple<br />

University.<br />

Kumar has developed new methods and algorithms<br />

for big data, and has translated them<br />

into widely used software packages and knowledge<br />

bases, such as MEGA and TimeTree. He<br />

uses integrative and comparative approaches to<br />

make fundamental discoveries in the fields of<br />

molecular evolution, functional genomics, and<br />

biomedicine.<br />

Kumar’s research has been cited more than<br />

90,000 times. One of his scientific articles was<br />

included in the Thomson Reuters Web of <strong>Science</strong><br />

top-100 most-cited papers of all time and<br />

designated the top article of the decade by the<br />

Scopus database of peer-reviewed literature.<br />

He received an Innovation Award in Functional<br />

Genomics from the Burroughs-Wellcome Fund<br />

in 2000 and is a fellow of American Association<br />

for the Advancement of <strong>Science</strong>.<br />

In 1998, Kumar joined the Arizona State University<br />

as an assistant professor and became the<br />

Regents Professor in 2012. Kumar joined Temple<br />

University in 2014 as the founding director<br />

of the Institute for Genomics and Evolutionary<br />

Medicine, a hub for transdisciplinary research<br />

in medicine, informatics, and molecular evolution.<br />

Kumar received his bachelor’s degree in electrical<br />

and electronics engineering and master’s<br />

degree in biology from the Birla Institute<br />

of Technology & <strong>Science</strong> in India in 1990. He<br />

completed his Ph.D. degree in genetics at Penn<br />

State in 1996.<br />

Caryl Russo Singer is the senior vice president<br />

for Barnabas Health Corporate Care, a division<br />

of Barnabas Health, the largest healthcare<br />

system in New Jersey. Russo is responsible<br />

for the workers’ compensation program and employee<br />

health services for Barnabas Health and<br />

its more than 22,000 employees. Russo is responsible<br />

for the occupational-medicine services<br />

offered through Barnabas Health Corporate<br />

Care in six sites located throughout New Jersey.<br />

Prior to joining Barnabas Health, Russo was<br />

the director of marketing and communications<br />

for First Option Health Plan, a healthcare insurance<br />

provider in New Jersey. Additionally,<br />

Russo was the director of strategic communications<br />

for Enzon, Inc., a publicly traded biotechnology<br />

company.<br />

Russo is active with numerous business and<br />

civic organizations including the New Jersey<br />

Self Insured Association and the Monmouth-<br />

Ocean Development Council. She also serves<br />

as a member of the Eberly College of <strong>Science</strong><br />

Biotechnology Advisory Board, the Delta Dental<br />

Foundation Board of Directors, and the New<br />

Jersey Chapter Board of Directors of the Arthritis<br />

Foundation.<br />

After graduating with a bachelor's degree in<br />

60 Penn State Eberly College of <strong>Science</strong> SCIENCE JOURNAL <strong>December</strong> <strong>2015</strong><br />

61

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!